Site icon OncologyTube

Clinical Activity of Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma

Vadim S. Koshkin, MD Cleveland Clinic Taussig Cancer discusses Clinical Activity of Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL.

Exit mobile version